Prism Research Selects OmniComm Systems, Inc.' TrialOne (R) Suite to Automate Phase I Clinic Operations
FORT LAUDERDALE, Fla., March 5, 2013 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCBB:OMCM), one of the fastest growing companies in the EDC marketplace, today announced that its TrialOne® suite of applications has been chosen by Prism Research to automate their clinical trial operations and processes within their early phase clinic.